This review highlights the significant sex differences in metabolic cardiomyopathies, emphasizing the higher risk in diabetic women and the potential role of specific signaling pathways.
Answers are grounded in this paper and cite their sources.
Highlights greater diabetic cardiomyopathy burden in women; leaves open sex-specific trials and mechanisms.
In contrast to ischemic cardiomyopathies which are more common in men, women are over-represented in diabetic cardiomyopathies. Diabetes is a risk factor for cardiovascular disease; however, there is a sexual dimorphism in this risk factor: heart disease is five times more common in diabetic women but only two-times more common in diabetic men. Heart failure with preserved ejection fraction, which is associated with metabolic syndrome, is also more prevalent in women. This review will examine potential mechanisms for the sex differences in metabolic cardiomyopathies. Sex differences in metabolism, calcium handling, nitric oxide, and structural proteins will be evaluated. Nitric oxide synthase and PPARα exhibit sex differences and have also been proposed to mediate the development of hypertrophy and heart failure. We focused on a role for these signalling pathways in regulating sex differences in metabolic cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: